Ignite Creation Date:
2024-05-06 @ 2:24 PM
Last Modification Date:
2024-10-26 @ 1:30 PM
Study NCT ID:
NCT04307485
Status:
RECRUITING
Last Update Posted:
2023-10-06
First Post:
2020-03-08
Brief Title:
A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients
Sponsor:
Shanghai Tong Ren Hospital
Organization:
Shanghai Tong Ren Hospital
Study Overview
Official Title:
A Randomized Controlled sTudy of Low Dose vs Standard tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Senior Patients
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study the investigates try to confirm our hypothesis that low dose ticagrelor60mg had similar anti-platelets function compared with the standard dose ticagrelor in senior no less than 75 years oldacute coronary syndrome patients Totally 40 senior ACS patients will be divided into 2 groups randomly one month after PCI Group 1 will be treated with ticagrelor 90mg and aspirin 100mg after PCI for 12 months as the standard group Group 2 will be treated with ticagrelor 60mg plus aspirin 100 mg for 11 months after one month standard DAPT treatment The platelets function will be tested in VASP and TEG methods 2 months after PCI as the primary endpointsThe clinical events will be observed 12 months after PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None